La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Pacific Edge Gestion

Gestion contrôle des critères 2/4

Le PDG Pacific Edge's est Peter Meintjes, nommé en Jan2022, a un mandat de 2.58 ans. détient directement 0.081% des actions de la société, d'une valeur de NZ$ 66.93K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 2.9 ans et 8.1 ans.

Informations clés

Peter Meintjes

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDG	n/a
Durée du mandat du directeur général	2.7yrs
Propriété du PDG	0.08%
Durée moyenne d'occupation des postes de direction	3yrs
Durée moyenne du mandat des membres du conseil d'administration	8.2yrs

Mises à jour récentes de la gestion

Recent updates

Further Upside For Pacific Edge Limited (NZSE:PEB) Shares Could Introduce Price Risks After 33% Bounce

Sep 16

Lacklustre Performance Is Driving Pacific Edge Limited's (NZSE:PEB) 30% Price Drop

Dec 18

Fewer Investors Than Expected Jumping On Pacific Edge Limited (NZSE:PEB)

Jun 06

Pacific Edge Limited (NZSE:PEB) Annual Results: Here's What Analysts Are Forecasting For This Year

May 27

We're Hopeful That Pacific Edge (NZSE:PEB) Will Use Its Cash Wisely

May 23

Companies Like Pacific Edge (NZSE:PEB) Are In A Position To Invest In Growth

Sep 06

Pacific Edge (NZSE:PEB) Is In A Good Position To Deliver On Growth Plans

May 31

Pacific Edge (NZSE:PEB) Is In A Strong Position To Grow Its Business

Jan 17

We're Hopeful That Pacific Edge (NZSE:PEB) Will Use Its Cash Wisely

Jun 05

Pacific Edge Limited (NZSE:PEB): Are Analysts Optimistic?

May 14

Don't Ignore The Fact That This Insider Just Sold Some Shares In Pacific Edge Limited (NZSE:PEB)

Mar 21

Did The Underlying Business Drive Pacific Edge's (NZSE:PEB) Lovely 750% Share Price Gain?

Mar 13

Have Insiders Been Selling Pacific Edge Limited (NZSE:PEB) Shares?

Feb 14

Pacific Edge Limited's (NZSE:PEB) Profit Outlook

Jan 18

How Much Of Pacific Edge Limited (NZSE:PEB) Do Insiders Own?

Dec 23

Did You Participate In Any Of Pacific Edge's (NZSE:PEB) Incredible 434% Return?

Nov 21

PDG

Peter Meintjes

2.7yrs

Titularisation

Dr. Peter Meintjes served as a Chief Commercial Officer at Transplant Genomics, Inc., since April 2020. he serves as CEO at Pacific Edge Limited since January 17, 2022. He was responsible for leding the co...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Peter Meintjes	Chief Executive Officer	2.7yrs	pas de données	0.081% NZ$ 98.4k
Grant Gibson	Chief Financial Officer	4.8yrs	pas de données	0.020% NZ$ 24.7k
Darrell Morgan	Chief Operating Officer	1.9yrs	pas de données	pas de données
Justin Harvey	Chief Technology Officer	4.7yrs	pas de données	pas de données
Parry Guilford	Chief Scientific Officer & Member of Scientific Advisory Board	no data	NZ$134.00k	pas de données
Andrew McIntosh	Chief Digital Officer	3.3yrs	pas de données	pas de données
Glen Costin	President of Asia Pacific	no data	pas de données	pas de données
Tamer Aboushwareb	Chief Medical Officer	no data	pas de données	pas de données
David Levison	Executive Chairman & President of Pacific Edge Diagnostics USA	no data	NZ$53.00k	pas de données

3.0yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe de direction de PEB est considérée comme expérimentée (ancienneté moyenne 2.9 ans).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Parry Guilford	Chief Scientific Officer & Member of Scientific Advisory Board	no data	NZ$134.00k	pas de données
David Levison	Executive Chairman & President of Pacific Edge Diagnostics USA	no data	NZ$53.00k	pas de données
R. Spence	Member of Scientific Advisory Board	no data	pas de données	pas de données
Chris Gallaher	Independent Non-Executive Chairman of the Board	8.2yrs	NZ$115.00k	0.12% NZ$ 150.0k
Osamu Ogawa	Member of Scientific Advisory Board	no data	pas de données	pas de données
Bryan Raymond Williams	Member of Scientific Advisory Board & Independent Deputy Non-Executive Chairman	11.3yrs	NZ$70.00k	0.075% NZ$ 91.5k
Michael Sullivan	Member of Scientific Advisory Board	no data	pas de données	pas de données
Nikola Kasabov	Member of Scientific Advisory Board	no data	pas de données	pas de données
Murray Brennan	Member of Scientific Advisory Board	no data	pas de données	pas de données
Anatole G. Masfen	Independent Non-Executive Director	16.4yrs	NZ$60.00k	1.15% NZ$ 1.4m
Anna Stove	Independent Non-Executive Director	3.5yrs	NZ$65.00k	0.00062% NZ$ 755.1
Sarah Park	Independent Non-Executive Director	5.8yrs	NZ$70.00k	0.0072% NZ$ 8.8k

8.2yrs

Durée moyenne de l'emploi

75yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de PEB sont considérés comme expérimentés (ancienneté moyenne 8.1 ans).

Pacific Edge Gestion

Gestion contrôle des critères 2/4

Informations clés

Mises à jour récentes de la gestion

Pacific Edge Limited, Annual General Meeting, Sep 24, 2024

Insufficient new directors

Pacific Edge Limited Announces Board Changes

Independent Non-Executive Director recently bought NZ$3.1m worth of stock

Key Executive recently bought NZ$54k worth of stock

Pacific Edge Limited Appoints Darrell Morgan as Chief Operating Officer

Recent updates

Further Upside For Pacific Edge Limited (NZSE:PEB) Shares Could Introduce Price Risks After 33% Bounce

Here's Why We're Watching Pacific Edge's (NZSE:PEB) Cash Burn Situation

Full year 2024 earnings released: NZ$0.036 loss per share (vs NZ$0.033 loss in FY 2023)

No longer forecast to breakeven

Pacific Edge Limited, Annual General Meeting, Sep 24, 2024

Pacific Edge Limited to Report Fiscal Year 2024 Results on May 21, 2024

Investors Holding Back On Pacific Edge Limited (NZSE:PEB)

Insufficient new directors

Pacific Edge Limited Announces Board Changes

Here's Why We're Watching Pacific Edge's (NZSE:PEB) Cash Burn Situation

Lacklustre Performance Is Driving Pacific Edge Limited's (NZSE:PEB) 30% Price Drop

Consensus EPS estimates upgraded to NZ$0.034 loss

First half 2024 earnings released: NZ$0.019 loss per share (vs NZ$0.013 loss in 1H 2023)

Pacific Edge Limited to Report First Half, 2024 Results on Nov 23, 2023

Price target decreased by 7.8% to NZ$0.15

Independent Non-Executive Director recently bought NZ$3.1m worth of stock

Key Executive recently bought NZ$54k worth of stock

Price target decreased by 34% to NZ$0.38

Pacific Edge Limited Announces Medicare Coverage of Cxbladder Tests in the US Market is Expected to Cease from 17 July 2023

Fewer Investors Than Expected Jumping On Pacific Edge Limited (NZSE:PEB)

Pacific Edge Limited (NZSE:PEB) Annual Results: Here's What Analysts Are Forecasting For This Year

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Forecast to breakeven in 2026

We're Hopeful That Pacific Edge (NZSE:PEB) Will Use Its Cash Wisely

Pacific Edge Announces the Acceptance for Publication of New Clinical Evidence That Shows Significant Improvements in the Performance of its Genomic Diagnostic Cxbladder Tests

Consensus forecasts updated

First half 2023 earnings released: NZ$0.013 loss per share (vs NZ$0.012 loss in 1H 2022)

Price target decreased to NZ$0.61

Companies Like Pacific Edge (NZSE:PEB) Are In A Position To Invest In Growth

Price target decreased to NZ$0.72

Pacific Edge Limited Appoints Darrell Morgan as Chief Operating Officer

Pacific Edge Limited to Report First Half, 2023 Results on Nov 26, 2022

Consensus revenue estimates fall by 27%

Pacific Edge (NZSE:PEB) Is In A Good Position To Deliver On Growth Plans

Now 26% undervalued after recent price drop

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to NZ$1.11

Pacific Edge Limited Announces It Is Advancing Its Clinical Evidence Generation Program with Lobster

Insufficient new directors

Consensus forecasts updated

Price target decreased to NZ$1.32

Pacific Edge (NZSE:PEB) Is In A Strong Position To Grow Its Business

Insufficient new directors

Consensus revenue estimates fall to NZ$12.9m

First half 2022 earnings: EPS and revenues exceed analyst expectations

No longer forecast to breakeven

CEO, MD & Executive Director exercised options to buy NZ$478k worth of stock.

Consensus EPS estimates fall to -NZ$0.014

We're Hopeful That Pacific Edge (NZSE:PEB) Will Use Its Cash Wisely

Full year 2021 earnings released: NZ$0.02 loss per share (vs NZ$0.032 loss in FY 2020)

Pacific Edge Limited (NZSE:PEB): Are Analysts Optimistic?

Insider recently sold NZ$130k worth of stock

Don't Ignore The Fact That This Insider Just Sold Some Shares In Pacific Edge Limited (NZSE:PEB)

Insider recently sold NZ$120k worth of stock

Did The Underlying Business Drive Pacific Edge's (NZSE:PEB) Lovely 750% Share Price Gain?

Have Insiders Been Selling Pacific Edge Limited (NZSE:PEB) Shares?

Analysts update estimates

Pacific Edge Limited's (NZSE:PEB) Profit Outlook

Pacific Edge Limited, Annual General Meeting, Jul 29, 2021

Pacific Edge Limited to Report First Half, 2022 Results on Nov 26, 2021

How Much Of Pacific Edge Limited (NZSE:PEB) Do Insiders Own?

New 90-day high: NZ$1.08

New 90-day high: NZ$0.78

First half 2021 earnings released: NZ$0.01 loss per share

Did You Participate In Any Of Pacific Edge's (NZSE:PEB) Incredible 434% Return?

Pacific Edge Limited Announces Management Changes

Pacific Edge Diagnostics Notifies the CMS LCD Coverage for Cxbladder

Pacific Edge Limited to Report Q2, 2021 Results on Nov 26, 2020